Exogenous tetrahydrobiopterin supplementation ameliorates heart failure with preserved ejection fraction by attenuating metabolic dysregulation and cardiac oxidative stress

11 May 2026 (16:12 - 17:30)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pharmacotherapy (1) Pharmacotherapy Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by